Global Cobalamin API Market Growth 2025-2031
The global Cobalamin API market size is predicted to grow from US$ 448 million in 2025 to US$ 522 million in 2031; it is expected to grow at a CAGR of 2.6% from 2025 to 2031.
Cobalamin API (cobalamin API) is a cobalt-containing vitamin B12 derivative with important biological activity. It is involved in processes such as erythropoiesis, maintenance of nerve function and DNA synthesis in the body. Cobalamin API is widely used to treat vitamin B12 deficiency, anemia and neurological diseases. As a pharmaceutical raw material, cobalamin API is used to prepare oral or injectable dosage forms to help improve metabolic function and nerve health in the body.
Key Features
- Global market predicted to grow from US$ 448 million in 2025 to US$ 522 million in 2031.
- CAGR of 2.6% from 2025 to 2031.
- Key players include Teva (Actavis), Jamieson, Novartis, Bayer HealthCare, Merck, among others.
Segmentation by type
- Purity≥99%
- Purity<99%
Segmentation by application
- Cobalamin Injection
- Oral Cobalamin
- Cobalamin Spray
Market by region
- Americas
- APAC
- Europe
- Middle East & Africa
Company's coverage
- Teva (Actavis)
- Jamieson
- Novartis
- Bayer HealthCare
- Merck
- Luitpold Pharmaceuticals (Daiichi Sankyo)
- Endo International
- Sanofi-Aventis
- Pfizer
- RLG Group
- CCEPCD
- Mylan
- ANGELINI
- Huaxin Pharmaceutical
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Cobalamin API market?
- What factors are driving Cobalamin API market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Cobalamin API market opportunities vary by end market size?
- How does Cobalamin API break out by Type, by Application?
Frequently Asked Questions
Cobalamin API report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cobalamin API report is categorised based on following features:
- Global Market Players
- Geopolitical regions
- Consumer Insights
- Technological advancement
- Historic and Future Analysis of the Market
Cobalamin API report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.